Stress & Social Cognition in BPD (Part 2)

• Status: Recruiting
• Trial end date: 2023-12-22
• Target enrollment: 0
• Participant gender: Female

Summary

The investigators will examine how a combination of pharmacological mineralocorticoid receptor (MR) stimulation and psychosocial stress will influence prosocial behavior in patients with Borderline Personality Disorder (BPD) compared to healthy controls (HC).

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Charite University, Berlin, Germany
• Treatments: Fludrocortisone

Criteria

Inclusion Criteria:

• female patients with BPD and healthy control women, matched for age, body mass index, and education, BMI between 17.5-30

Exclusion Criteria:

• acute depressive episode, acute or lifetime psychotic symptoms, acute substance abuse, physical illness